« Back
Home /
PF-06835919

PF-06835919

Item no.	DCC-DC30002-100mg
Manufacturer	DCChemicals
CASRN	2102501-84-6
Amount	100 mg
Quantity options	100 mg 10 mg 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Purity	>98%
Smiles	FC(C1=CC(=NC(=N1)N1CC[C@@H]1C)N1C[C@H]2C(CC(=O)O)[C@H]2C1)(F)F
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	PF-06835919,PF 06835919,PF06835919
Similar products	2102501-84-6
Available
Manufacturer - Applications	PF-06835919, also known as MDK1846, is a potent ketohexokinase (KHK) inhibitor. PF-06835919 is reported in patent US 20170183328 A1, example 4. Increased fructose consumption and its subsequent metabolism have been implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance in humans. Since ketohexokinase (KHK) is the principal enzyme responsible for fructose metabolism, identification of a selective KHK inhibitor may help to further elucidate the effect of KHK inhibition on these metabolic disorders.
Molecular Weight	356, 342873811722
Chemical name	PF-06835919

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 6/26/2025